Target intelligence / Profile preview

Peripheral voltage-gated sodium channel (Peripheral VGSC)

Target
Peripheral VGSC
Molecular classification
Ion channel, Voltage-gated ion channel, Sodium channel
01

Overview

Voltage-gated sodium channels (VGSCs) in peripheral sensory neurons, specifically the Nav1.7, Nav1.8, and Nav1.9 isoforms, are essential for the transmission of pain signals from the periphery to the central nervous system [1, 2, 4]. These channels are primarily expressed in nociceptors within the dorsal root and trigeminal ganglia [6, 11]. Nav1.7 acts as a threshold channel that amplifies generator potentials to trigger action potentials, while Nav1.8 and Nav1.9 are responsible for the upstroke and maintenance of these signals, particularly under pathological conditions [2, 4, 6]. Mutations in the genes encoding these channels (SCN9A, SCN10A, SCN11A) lead to various pain disorders, including erythromelalgia and congenital insensitivity to pain [5, 10, 17]. Due to their localized expression, they are prime targets for developing non-opioid analgesics that avoid central nervous system and cardiac side effects [6, 10]. Therapeutic approaches include non-selective blockers like lidocaine and newer, isoform-selective inhibitors such as the Nav1.8-selective blocker suzetrigine [8, 13].

Other names
Nav1.7Nav1.8Nav1.9SCN9ASCN10ASCN11ANociceptor-specific sodium channelsTTX-resistant sodium channelsTTX-sensitive sodium channelsPeripheral sodium channels
02

Mechanism of action

Voltage-gated sodium channel inhibition, Sodium channel blockade

03

Biological functions

Signal transductionAction potential generationAction potential propagationNociceptionSensory perception
04

Disease associations

Neuropathic painInflammatory painErythromelalgiaParoxysmal extreme pain disorderCongenital insensitivity to painSmall fiber neuropathy
05

Safety considerations

Central nervous system side effects (e.g., dizziness, somnolence)Cardiac arrhythmias (due to Nav1.5 cross-reactivity)Selectivity for peripheral vs. central/cardiac isoformsPotential for numbness or loss of protective sensation
06

Interacting drugs

Lidocaine

10 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS)Numeric Rating Scale (NRS)Quantitative Sensory Testing (QST)Intraepidermal nerve fiber density (IENFD)SCN9A genotypingSCN10A genotypingSCN11A genotyping

Beyond the preview

Go deeper on Peripheral voltage-gated sodium channel (Peripheral VGSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral voltage-gated sodium channel (Peripheral VGSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call